Lexaria Research Development from 2010 to 2024

LEXXW Stock  USD 0.80  0.05  6.67%   
Lexaria Bioscience Research Development yearly trend continues to be fairly stable with very little volatility. Research Development will likely drop to about 1.2 M in 2024. During the period from 2010 to 2024, Lexaria Bioscience Research Development regression line of quarterly data had mean square error of 535.1 B and geometric mean of  337,360. View All Fundamentals
 
Research Development  
First Reported
2014-09-30
Previous Quarter
573.1 K
Current Value
967.2 K
Quarterly Volatility
343.4 K
 
Yuan Drop
 
Covid
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 K, Interest Expense of 125.2 K or Other Operating Expenses of 3.2 M, as well as many indicators such as Price To Sales Ratio of 105, Dividend Yield of 0.0 or PTB Ratio of 54.87. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Research Development Growth Pattern

Below is the plot of the Research Development of Lexaria Bioscience Corp over the last few years. It is Lexaria Bioscience's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Lexaria Research Development Regression Statistics

Arithmetic Mean836,644
Geometric Mean337,360
Coefficient Of Variation126.68
Mean Deviation818,032
Median387,074
Standard Deviation1,059,830
Sample Variance1.1T
Range3.7M
R-Value0.75
Mean Square Error535.1B
R-Squared0.56
Significance0
Slope176,970
Total Sum of Squares15.7T

Lexaria Research Development History

20241.2 M
20232.4 M
20223.7 M
20211.8 M
20201.3 M
2019387.1 K
2018555.7 K

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Research Development, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development2.4 M1.2 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.